MannKind Corporation (MNKD): Price and Financial Metrics

MNKD POWR Grades

• Value is the dimension where MNKD ranks best; there it ranks ahead of 50.89% of US stocks.
• The strongest trend for MNKD is in Quality, which has been heading down over the past 179 days.
• MNKD's current lowest rank is in the Growth metric (where it is better than 1.1% of US stocks).

MNKD Stock Summary

• The capital turnover (annual revenue relative to shareholder's equity) for MNKD is -0.36 -- better than merely 4.94% of US stocks.
• Equity multiplier, or assets relative to shareholders' equity, comes in at -1.51 for Mannkind Corp; that's greater than it is for only 4.51% of US stocks.
• With a year-over-year growth in debt of 210.07%, Mannkind Corp's debt growth rate surpasses 94.73% of about US stocks.
• Stocks that are quantitatively similar to MNKD, based on their financial statements, market capitalization, and price volatility, are ZKIN, CYRX, ACRX, KALA, and ATEC.
• Visit MNKD's SEC page to see the company's official filings. To visit the company's web site, go to www.mannkindcorp.com.

MNKD Valuation Summary

• MNKD's price/earnings ratio is -13.9; this is 138.08% lower than that of the median Healthcare stock.
• Over the past 208 months, MNKD's price/sales ratio has gone NA NA.
• Over the past 208 months, MNKD's price/sales ratio has gone NA NA.

Below are key valuation metrics over time for MNKD.

MNKD Growth Metrics

Its 3 year net income to common stockholders growth rate is now at 80.29%.
• The 2 year revenue growth rate now stands at 406.72%.
• Its 4 year net cashflow from operations growth rate is now at 3.19%.

MNKD's revenue has moved up $33,600,000 over the prior 34 months.

The table below shows MNKD's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	75.442	-61.709	-80.926
2021-09-30	81.37	-49.127	-79.276
2021-06-30	74.511	-47.403	-86.105
2021-03-31	66.345	-29.64	-60.834
2020-12-31	65.144	-28.128	-57.24
2020-09-30	62.694	-33.47	-45.092

MNKD's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• MNKD has a Quality Grade of C, ranking ahead of 42.97% of graded US stocks.
• MNKD's asset turnover comes in at 0.384 -- ranking 124th of 680 Pharmaceutical Products stocks.
• VERU, PLX, and LGND are the stocks whose asset turnover ratios are most correlated with MNKD.

The table below shows MNKD's key quality metrics over time.